Ignite Creation Date:
2025-12-24 @ 7:10 PM
Ignite Modification Date:
2026-05-01 @ 1:23 PM
Study NCT ID:
NCT02726503
Status:
COMPLETED
Last Update Posted:
2020-06-17
First Post:
2016-03-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study Assessing the Efficacy and Safety of Lenvatinib for Anaplastic Thyroid Cancer
Sponsor:
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
TRIHN1504
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None